Knockdown of Virus Antigen Expression Increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus Carrier Mice
Thomas Michler(Helmholtz Zentrum München), Ulrike Protzer(German Center for Infection Research), Anna D. Kosinska(Helmholtz Zentrum München), Carlos A. Guzmán(Helmholtz Centre for Infection Research), Marc Ringelhan(Technical University of Munich), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Dirk Grimm(Heidelberg University), Hortenzia Imhof(Helmholtz Munich), Till Bunse(Helmholtz Zentrum München), Carolin Mogler(TUM Klinikum), Percy A. Knolle(TUM Klinikum), Julia Festag(Helmholtz Munich), Stuart Milstein(Alnylam Pharmaceuticals (United States)), Jinpeng Su(Helmholtz Munich), Katja Steiger(Technical University of Munich), Marie-Louise Michel(Institut Pasteur), Mathias Heikenwälder(University of Tübingen)
Cited by 130
Related Papers
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
The maternal microbiota drives early postnatal innate immune development
|Science|2016|1.2k
Therapeutic siRNA silencing in inflammatory monocytes in mice
|Nature Biotechnology|2011|837